Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Zhaonian Hao"'
Autor:
Jiejun Wang, Zhaonian Hao, Ruyuan Li, Weiqi Wu, Na Huang, Kangna Zhang, Shuyu Hao, Jie Feng, Junsheng Chu, Nan Ji
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
BackgroundThe prognostic value of body mass index (BMI) in primary WHO grade 4 gliomas is not widely acknowledged. This study aims to assess the survival outcomes of patients with different BMIs.MethodsReal-world data of patients diagnosed with prima
Externí odkaz:
https://doaj.org/article/880a61af73a24e05ac23682370e25c0c
Publikováno v:
Biomarker Research, Vol 9, Iss 1, Pp 1-28 (2021)
Abstract Myeloid-derived suppressor cells (MDSC) are a group of immature cells that produced by emergency myelopoiesis. Emerging evidences have identified the vital role of MDSC in cancer microenvironment, in which MDSC exerts both immunological and
Externí odkaz:
https://doaj.org/article/e9b6aabb2c6c4539949200b839f6087f
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
BackgroundThe tightly controlled activity of EGFR is important for the homeostasis of self-renewal of human tissue. Mutations in the extracellular domain of EGFR are frequent and function as a novel mechanism for oncogenic EGFR activation in GBM, and
Externí odkaz:
https://doaj.org/article/2670984517e24ce683f039855e7aaf40
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
Glioblastoma is the most common primary malignant tumor in the brain and has a dismal prognosis despite patients accepting standard therapies. Alternation of genes and deregulation of proteins, such as receptor tyrosine kinase, PI3K/Akt, PKC, Ras/Raf
Externí odkaz:
https://doaj.org/article/d253a7578ade41eea34c23645dd2c7d3
Publikováno v:
Experimental Hematology & Oncology, Vol 9, Iss 1, Pp 1-12 (2020)
Abstract Chimeric antigen receptor (CAR) T cell therapy is a new frontier in cancer therapy. The toxicity of cytokine release syndrome (CRS) has become one of the major challenges that limits the wider use of CAR T cells to fight cancer. Exploration
Externí odkaz:
https://doaj.org/article/2b2cb45c0d6c45c893ee6947d97bc5e9
Autor:
Zhaonian Hao, Dongsheng Guo
Publikováno v:
BMC Cancer, Vol 19, Iss 1, Pp 1-13 (2019)
Abstract Background Glioma is one of the most common type of primary central nervous system tumors. EGFR mutation, a common alteration occurs in various tumors, is not brought to the forefront in understanding and treating glioma at present. Methods
Externí odkaz:
https://doaj.org/article/69041a2493b4413688804bffb67d2a53
Publikováno v:
Global Challenges, Vol 5, Iss 6, Pp n/a-n/a (2021)
Abstract The novel D614G linage is becoming the dominating species of SARS‐CoV‐2. The impact of meteorological and geographical factors on SARS‐CoV‐2 pandemic are presently not well understood. This research article presents a retrospective c
Externí odkaz:
https://doaj.org/article/9ffc558f5b47402f9b8c12f5fc857180
Publikováno v:
Biomarker Research, Vol 10, Iss 1, Pp 1-1 (2022)
Externí odkaz:
https://doaj.org/article/f5cb8396557f4f05b32c464815f1bdee
Publikováno v:
Experimental Hematology & Oncology, Vol 9, Iss 1, Pp 1-12 (2020)
Experimental Hematology & Oncology
Experimental Hematology & Oncology
Chimeric antigen receptor (CAR) T cell therapy is a new frontier in cancer therapy. The toxicity of cytokine release syndrome (CRS) has become one of the major challenges that limits the wider use of CAR T cells to fight cancer. Exploration of CRS pa
Publikováno v:
Biomarker Research, Vol 9, Iss 1, Pp 1-28 (2021)
Biomarker Research
Biomarker Research
Myeloid-derived suppressor cells (MDSC) are a group of immature cells that produced by emergency myelopoiesis. Emerging evidences have identified the vital role of MDSC in cancer microenvironment, in which MDSC exerts both immunological and non-immun